143 related articles for article (PubMed ID: 30945120)
1. Does neoadjuvant chemotherapy cancel out the negative survival impact induced by surgical complications after gastrectomy?
Hayashi M; Yoshikawa T; Yura M; Otsuki S; Yamagata Y; Morita S; Katai H; Nishida T
Gastric Cancer; 2019 Nov; 22(6):1274-1284. PubMed ID: 30945120
[TBL] [Abstract][Full Text] [Related]
2. Outcomes of preoperative S-1 and docetaxel combination chemotherapy in patients with locally advanced gastric cancer.
Kosaka T; Akiyama H; Miyamoto H; Sato S; Tanaka Y; Sato K; Kunisaki C; Endo I
Cancer Chemother Pharmacol; 2019 Jun; 83(6):1047-1055. PubMed ID: 30911769
[TBL] [Abstract][Full Text] [Related]
3. Gastrectomy with or without neoadjuvant S-1 plus cisplatin for type 4 or large type 3 gastric cancer (JCOG0501): an open-label, phase 3, randomized controlled trial.
Iwasaki Y; Terashima M; Mizusawa J; Katayama H; Nakamura K; Katai H; Yoshikawa T; Ito S; Kaji M; Kimura Y; Hirao M; Yamada M; Kurita A; Takagi M; Lee SW; Takagane A; Yabusaki H; Hihara J; Boku N; Sano T; Sasako M
Gastric Cancer; 2021 Mar; 24(2):492-502. PubMed ID: 33200303
[TBL] [Abstract][Full Text] [Related]
4. Posttherapy topographical nodal status, ypN-site, predicts survival of patients who received neoadjuvant chemotherapy followed by curative surgical resection for non-type 4 locally advanced gastric cancer: supplementary analysis of JCOG1004-A.
Fujitani K; Nakamura K; Mizusawa J; Kuwata T; Shimoda T; Katayama H; Kushima R; Taniguchi H; Yoshikawa T; Boku N; Terashima M; Fukuda H; Sano T; Sasako M;
Gastric Cancer; 2021 Jan; 24(1):197-204. PubMed ID: 32572792
[TBL] [Abstract][Full Text] [Related]
5. Impact of Neoadjuvant Chemotherapy Among Patients with Pancreatic Fistula After Gastrectomy for Advanced Gastric Cancer.
Kosaka T; Akiyama H; Makino H; Kimura J; Takagawa R; Ono HA; Kunisaki C; Endo I
Anticancer Res; 2016 Apr; 36(4):1773-7. PubMed ID: 27069158
[TBL] [Abstract][Full Text] [Related]
6. Role of D2 gastrectomy in gastric cancer with clinical para-aortic lymph node metastasis.
Zheng XH; Zhang W; Yang L; Du CX; Li N; Xing GS; Tian YT; Xie YB
World J Gastroenterol; 2019 May; 25(19):2338-2353. PubMed ID: 31148905
[TBL] [Abstract][Full Text] [Related]
7. [Prognostic analysis of neoadjuvant chemotherapy for locally advanced gastric cancer with propensity score matching method].
Peng L; Yang W; Zhang Z; Zhi C; Zhou X; Liu H; Hua Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Oct; 21(10):1148-1153. PubMed ID: 30370514
[TBL] [Abstract][Full Text] [Related]
8. The Negative Survival Impact of Infectious Complications After Surgery is Canceled Out by the Response of Neoadjuvant Chemotherapy in Patients with Esophageal Cancer.
Kano K; Aoyama T; Yoshikawa T; Maezawa Y; Nakajima T; Hayashi T; Yamada T; Sato T; Oshima T; Rino Y; Masuda M; Cho H; Ogata T
Ann Surg Oncol; 2018 Jul; 25(7):2034-2043. PubMed ID: 29748890
[TBL] [Abstract][Full Text] [Related]
9. Neoadjuvant chemotherapy for gastric cancer. Is it a must or a fake?
Reddavid R; Sofia S; Chiaro P; Colli F; Trapani R; Esposito L; Solej M; Degiuli M
World J Gastroenterol; 2018 Jan; 24(2):274-289. PubMed ID: 29375213
[TBL] [Abstract][Full Text] [Related]
10. Posttherapy nodal status, not graded histologic response, predicts survival after neoadjuvant chemotherapy for advanced gastric cancer.
Fujitani K; Mano M; Hirao M; Kodama Y; Tsujinaka T
Ann Surg Oncol; 2012 Jun; 19(6):1936-43. PubMed ID: 22187120
[TBL] [Abstract][Full Text] [Related]
11. Postoperative nodal status and diffuse-type histology are independent prognostic factors in resectable advanced gastric carcinomas after preoperative chemotherapy.
Koh YW; Park YS; Ryu MH; Ryoo BY; Park HJ; Yook JH; Kim BS; Kang YK
Am J Surg Pathol; 2013 Jul; 37(7):1022-9. PubMed ID: 23715160
[TBL] [Abstract][Full Text] [Related]
12. Prophylactic effect of neoadjuvant chemotherapy in gastric cancer patients with postoperative complications.
Eto K; Hiki N; Kumagai K; Shoji Y; Tsuda Y; Kano Y; Yasufuku I; Okumura Y; Tsujiura M; Ida S; Nunobe S; Ohashi M; Sano T; Yamaguchi T
Gastric Cancer; 2018 Jul; 21(4):703-709. PubMed ID: 29188456
[TBL] [Abstract][Full Text] [Related]
13. An integrated analysis of two phase II trials (JCOG0001 and JCOG0405) of preoperative chemotherapy followed by D3 gastrectomy for gastric cancer with extensive lymph node metastasis.
Katayama H; Tsuburaya A; Mizusawa J; Nakamura K; Katai H; Imamura H; Nashimoto A; Fukushima N; Sano T; Sasako M
Gastric Cancer; 2019 Nov; 22(6):1301-1307. PubMed ID: 31264058
[TBL] [Abstract][Full Text] [Related]
14. [Clinical features and prognosis analysis of 21 gastric cancer patients with pathological complete response after neoadjuvant chemotherapy].
Peng L; Yang W; Zhang Z; Liu H; Hua Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Oct; 20(10):1168-1173. PubMed ID: 29130233
[TBL] [Abstract][Full Text] [Related]
15. Effects of Neoadjuvant Chemotherapy Toxicity and Postoperative Complications on Short-term and Long-term Outcomes After Curative Resection of Gastric Cancer.
Wu C; Wang N; Zhou H; Wang T; Mao Q; Zhang X; Zhao D
J Gastrointest Surg; 2020 Jun; 24(6):1278-1289. PubMed ID: 31140064
[TBL] [Abstract][Full Text] [Related]
16. Phase II trial of preoperative S-1 plus cisplatin followed by surgery for initially unresectable locally advanced gastric cancer.
Inoue K; Nakane Y; Kogire M; Fujitani K; Kimura Y; Imamura H; Tamura S; Okano S; Kwon AH; Kurokawa Y; Shimokawa T; Takiuchi H; Tsujinaka T; Furukawa H
Eur J Surg Oncol; 2012 Feb; 38(2):143-9. PubMed ID: 22154885
[TBL] [Abstract][Full Text] [Related]
17. Pathological evaluation of neoadjuvant chemotherapy in advanced gastric cancer.
Hu SB; Liu CH; Wang X; Dong YW; Zhao L; Liu HF; Cao Y; Zhong DR; Liu W; Li YL; Gao WS; Bai CM; Shang ZH; Li XY
World J Surg Oncol; 2019 Jan; 17(1):3. PubMed ID: 30606195
[TBL] [Abstract][Full Text] [Related]
18. Pathological response measured using virtual microscopic slides for gastric cancer patients who underwent neoadjuvant chemotherapy.
Kawai S; Shimoda T; Nakajima T; Terashima M; Omae K; Machida N; Yasui H
World J Gastroenterol; 2019 Sep; 25(35):5334-5343. PubMed ID: 31558877
[TBL] [Abstract][Full Text] [Related]
19. A phase II study of neoadjuvant chemotherapy with docetaxel, cisplatin, and S-1, followed by gastrectomy with D2 lymph node dissection for high-risk advanced gastric cancer: results of the KDOG1001 trial.
Hosoda K; Azuma M; Katada C; Moriya H; Mieno H; Ishido K; Ema A; Ushiku H; Wada T; Washio M; Watanabe A; Higuchi K; Tanabe S; Koizumi W; Watanabe M; Yamashita K
Gastric Cancer; 2019 May; 22(3):598-606. PubMed ID: 30284080
[TBL] [Abstract][Full Text] [Related]
20. Impact of anaemia in oesophago-gastric cancer patients undergoing curative treatment by means of neoadjuvant chemotherapy and surgery.
Chan BY; McKinlay S; Forshaw M; MacDonald A; Maitra R; Orizu M; McSorley ST
Surg Oncol; 2021 Sep; 38():101585. PubMed ID: 33930843
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
